2-Chlorodeoxyadenosine. 1992

D L Betcher, and N Burnham

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017338 Cladribine An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. 2-Chloro-2'-deoxyadenosine,2-Chlorodeoxyadenosine,2'-Deoxy-2-chloroadenosine,Leustatin

Related Publications

D L Betcher, and N Burnham
October 1992, Lancet (London, England),
D L Betcher, and N Burnham
March 1993, The New England journal of medicine,
D L Betcher, and N Burnham
February 1993, Nouvelle revue francaise d'hematologie,
D L Betcher, and N Burnham
May 1995, Annals of oncology : official journal of the European Society for Medical Oncology,
D L Betcher, and N Burnham
January 1994, Seminars in hematology,
D L Betcher, and N Burnham
February 1993, Blood,
D L Betcher, and N Burnham
October 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D L Betcher, and N Burnham
September 1994, European journal of haematology,
D L Betcher, and N Burnham
January 1996, Cancer treatment and research,
D L Betcher, and N Burnham
January 1996, Przeglad lekarski,
Copied contents to your clipboard!